Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs| (NASDAQ: ASMB) | Delayed: 35.18 +1.55 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.63 | 52 Week High | $14.50 | |||
| Open | $34.12 | 52 Week Low | $4.33 | |||
| Day High | $35.33 | P/E | N/A | |||
| Day Low | $33.43 | EPS | $0.00 | |||
| Volume | 301,100 | |||||

